Mr. Ashish Malik reports

BEE VECTORING TECHNOLOGIES ANNOUNCES FIRST SALE OF CR-7 TO BIOSAFE FOR FOLIAR APPLICATION

Bee Vectoring Technologies International Inc. has received its first sales order of Bee Vectoring's clonostachys rosea CR-7 proprietary microbe for use in the foliar application market. This groundbreaking deal is with BioSafe Systems, an industry leader in environmentally sustainable products. This is the result of an earlier announcement of a commercial agreement between Bee Vectoring and BioSafe to develop and market end-use biological products for plant health and control of foliar and soil diseases.

"Not only is this Bee Vectoring's first sale to a larger Ag-inputs company, it's also an entry into a totally new market and revenue source, giving us access to markets where bees are not used for the first time," said Ashish Malik, chief executive officer of Bee Vectoring. "This confirms that our strategy to expand business to channel partners like BioSafe is working well and paying dividends, as it enables us to scale growth and expand market share much more quickly."

This inaugural sale of technical-grade CR-7 marks Bee Vectoring's entry into the foliar business. BioSafe will take CR-7, use it to create a proprietary formulation and sell it to its distribution network in the foliar market. Bee Vectoring will receive a royalty for every BioSafe sale.

"We've also just finished characterizing CR-7 for the control of various diseases across multiple crops," said Dr. Mason Newark, field technical manager at Bee Vectoring. "This validates CR-7 as a broad-spectrum biofungicide across many crops and creates a solid foundation for building up our foliar business."

The deal with BioSafe is a key milestone in Bee Vectoring's continuing corporate expansion strategy. "Entering the foliar business expands our market in exciting new ways," said Mr. Malik. "It demonstrates successful execution of our business strategy, which is to focus on both geographic expansion and finding new applications for CR-7."

About Bee Vectoring Technologies International Inc.

Bee Vectoring, an agriculture technology company, is a market disruptor with a significant global market opportunity in the $240-billion crop protection and fertilizer market. Bee Vectoring has pioneered a natural precision agriculture system that replaces chemical pesticides and wasteful plant protection product spray applications by delivering biological pesticide alternatives to crops using commercially grown bees. Bee Vectoring's award-winning technology, precision vectoring, is completely harmless to bees and allows minute amounts of naturally derived pesticides (called biologicals) to be delivered directly to blooms, providing improved crop protection and yield results than traditional chemical pesticides -- and improving the health of the soil, the microbiome and the environment. Currently, Bee Vectoring has over 55 granted patents, over 35 patents pending in all major agricultural countries worldwide and has U.S. Environmental Protection Agency registration of its Vectorite with CR-7 (EPA registration No. 90641-2) for sale as a registered biological fungicide for use on the labelled crops.

We seek Safe Harbor.